Cargando…
Advances in the management of haemophilia: emerging treatments and their mechanisms
Mainstay haemophilia treatment, namely intravenous factor replacement, poses several clinical challenges including frequent injections due to the short half-life of recombinant factors, intravenous administration (which is particularly challenging in those with difficult venous access), and the risk...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442442/ https://www.ncbi.nlm.nih.gov/pubmed/34521404 http://dx.doi.org/10.1186/s12929-021-00760-4 |